Data protection, not from the privacy information, but data protection within the context of proposals made to increase the period of time under the patents issue of the pharmaceutical industry.
I understand the current regime in the United States is five and then three for a new system. Under the previous government, Industry Canada had been taking the position that it was eight years. There was no differentiation between the five and three. That's of concern to members. I don't think many of us have heard the case for it. Whether or not the minister will proceed with putting this in terms of regulations is a different matter, but we should hear from the minister before any decision is made.